Chiome Bioscience Inc. (4583.T)
JPY 132.0
(3.13%)
JPY 132.0
(3.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.21 Billion JPY | 2.18% |
| 2022 | -1.23 Billion JPY | 6.34% |
| 2021 | -1.46 Billion JPY | -2.96% |
| 2020 | -1.28 Billion JPY | 7.88% |
| 2019 | -1.39 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -258.68 Million JPY | 14.46% |
| 2024 Q1 | -302.45 Million JPY | -0.73% |
| 2023 Q3 | -253.52 Million JPY | 41.6% |
| 2023 Q2 | -434.13 Million JPY | -91.17% |
| 2023 Q1 | -227.09 Million JPY | -3.71% |
| 2023 FY | - JPY | 2.18% |
| 2023 Q4 | -300.41 Million JPY | -18.49% |
| 2022 Q3 | -259.75 Million JPY | 0.0% |
| 2022 FY | - JPY | 6.34% |
| 2022 Q4 | -218.97 Million JPY | 15.7% |
| 2021 FY | - JPY | -2.96% |
| 2020 FY | - JPY | 7.88% |
| 2019 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 226.473% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | -148.24% |
| GNI Group Ltd. | 14.48 Billion JPY | 108.363% |
| Linical Co., Ltd. | 1.24 Billion JPY | 197.154% |
| Trans Genic Inc. | 240.95 Million JPY | 602.896% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 10.629% |
| Soiken Holdings Inc. | -583.2 Million JPY | -107.772% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | -100.921% |
| AnGes, Inc. | -8.86 Billion JPY | 86.324% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 5.738% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 83.623% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 1045.879% |
| NanoCarrier Co., Ltd. | -863 Million JPY | -40.41% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | -10.987% |
| CanBas Co., Ltd. | 53.65 Million JPY | 2358.554% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | -56.234% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -983.834% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 12.245% |
| PeptiDream Inc. | 7.37 Billion JPY | 116.428% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 37.206% |
| Ribomic Inc. | -1.01 Billion JPY | -19.675% |
| SanBio Company Limited | -4.52 Billion JPY | 73.221% |
| Healios K.K. | -3 Billion JPY | 59.703% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -3.942% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 13.017% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 13.571% |
| StemRIM | -2.03 Billion JPY | 40.367% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 192.751% |
| FunPep Company Limited | -952 Million JPY | -27.283% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -36.34% |
| Stella Pharma Corporation | -723.85 Million JPY | -67.401% |
| TMS Co., Ltd. | -937 Million JPY | -29.321% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -56.274% |
| Cuorips Inc. | -518 Million JPY | -133.926% |
| K Pharma,Inc. | 366.05 Million JPY | 431.023% |
| Takara Bio Inc. | 8.02 Billion JPY | 115.101% |
| ReproCELL Incorporated | 8.24 Million JPY | 14796.628% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 1477.945% |
| StemCell Institute Inc. | 534.35 Million JPY | 326.767% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 594.962% |
| CellSeed Inc. | -836.51 Million JPY | -44.855% |